MINERVA CARDIOLOGY AND ANGIOLOGY, cilt.69, sa.2, ss.185-190, 2021 (SCI-Expanded)
BACKGROUND: Hypertriglyceridemia (HTG) is an important component of residual risk. The knowledge regarding its treatment might not be at a desired level which might prevent patients from receiving the maximum benefit. We aimed to investigate the knowledge and attitudes of Turkish cardiologists who responded to a survey regarding HTG treatment.